Assignee
ZHONG MINGHONG
US·3 granted patents·9 pending applications·69 citations·filing 2015–2025
Top patents by PatentIndex Score
12 records- 0195US10059940B2Chemically ligated RNAs for CRISPR/Cas9-lgRNA complexes as antiviral therapeutic agentsZHONG MINGHONG·Filed 2016·Granted Aug 28, 2018·66 cites·25 claims
- 0282US2024076661A1LgRNA-directed CRISPR Gene EditingZHONG MINGHONG·Filed 2023·Application pending·0 cites
- 0381US11667914B2Chemically ligated RNAs for CRISPR/Cas9-1gRNA complexes as antiviral therapeutic agentsZHONG MINGHONG·Filed 2018·Granted Jun 6, 2023·1 cites·22 claims
- 0479US9828409B2Bridged-cyclo-ProTides as prodrugs of therapeutic nucleosides and nucleotidesZHONG MINGHONG·Filed 2015·Granted Nov 28, 2017·2 cites·6 claims
- 0568US2025027115A1Conjugates of guide RNA-Cas protein complex for genome and epigenome editingZHONG MINGHONG·Filed 2024·Application pending·0 cites
- 0665US2018230464A1Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic AgentsZHONG MINGHONG·Filed 2018·Application pending·0 cites
- 0760US2021054371A1Conjugates of Guide RNA-Cas Protein ComplexZHONG MINGHONG·Filed 2020·Application pending·0 cites
- 0860US2023167441A1Segmented Nucleic AcidsZHONG MINGHONG·Filed 2022·Application pending·0 cites
- 0959US2025381301A1Conjugates of Guide RNA-Cas Protein ComplexZHONG MINGHONG·Filed 2020·Application pending·0 cites
- 1055US2025376664A1Virus-Ribonucleoprotein ConjugatesZHONG MINGHONG·Filed 2025·Application pending·0 cites
- 1151US2025263693A1Guide RNA Constructs for Therapeutic Gene EditingZHONG MINGHONG·Filed 2025·Application pending·0 cites
- 1233US2015376219A1Selective Preparations of Purine Nucleosides and Nucleotides: Reagents and MethodsZHONG MINGHONG·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →